The company seeks to accelerate drug development by automating analysis of study samples.

The transaction is expected to close on or about July 28, 2025, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering to fund ...

Kristin Cabot, Astronomer's HR chief, faces backlash after a viral kiss cam video and contradicted her public claims of ...

Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets ...

Greenboats is calling all developers of bio-based or recycled reinforcement fibres and core materials to send the company a sample and a datasheet. The company has created a library for scalable, ...

Dash's Fully Automated Bioanalysis Platform Is Reshaping Drug Development with Speed, Precision, and Scale. NEWTON, Mass., ...

While it seems like every industry will be affected in some way by agents, for the first time, the scale of a business is not ...

The factory network, which prioritizes next-generation leather alternatives, has teamed with one of California's preeminent ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.